last authored:
Glucose 6 Phosphate Dehydrogenase (G6PD) deficiency is the most common enzymatic disorder worldwide, affecting more than 200 million individuals. It causes bouts of acute hemolytic anemia following exposure to oxidizing substances.
Disease severity is classified by the magnitude of enzyme deficiency and degree of hemolysis.
a simple case introducing clincial presentation and calling for a differential diagnosis. To get students thinking.
X-linked disease, with multiple identified mutations. It has the highest prevalence in the Middle East, Africa and Asia, and parts of the Mediterranean. G6PD deficiency is thought to protect against infection by malaria.
Oxidants known to precipitate acute hemolytic anemia include fava beans, antimalarials such as primiquine, or sulfonamides.
Enzyme deficiency leads to RBCs that are unable to protect themselves against oxidative stress, as can follow infection or drugs. Hemoglobin precipitates out, forming Heinz bodies, and splenic macrophages begin phagocytosing RBCs to form 'bite cells' or 'cookie cells'.
Patients present with acute hemolytic anemia:
blood smear: bite cells and Heinz bodies are characteristic.
evidence of hemolytic anemia:
G6PD levels can also be measured.
Following acute attacks, treatment is supportive, especially hydration. Transfusions are given as required. Phototherapy can be used to degrade bilirubin.
Prevention, through the avoidance of known precipitants, is important.
Chronic anemia is rare.
Case #2 - a small story wrapping it all up and asking about esp management.
created:
authors:
editors:
reviewers: